Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome - Concepedia

Concepedia

Publication | Open Access

Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome

DOI Full Paper Access

66

Citations

45

References

2022

Year

Jeffrey L. Neul, Alan K. Percy, Tim A. Benke, Elizabeth Berry‐Kravis, Daniel G. Glaze, Sarika U. Peters, Nancy E. Jones, James M. Youakim

Contemporary Clinical Trials

Abstract

Clinicaltrials.govNCT04181723.

References

	Year	Citations

Page 1